Benzinga's Top Pre-Market Gainers

Integramed America Inc INMD surged 21.60% to $13.79 in the pre-market session. IntegraMed agreed to be bought by Sagard Capital Partners for $14.05 per share in cash. Ampio Pharmaceuticals Inc AMPE rose 10.94% to $3.55 in the pre-market trading. AMPE reported positive clinical trial results for the treatment of diabetic macular edema with orally administered Optina. Dean Foods Company DF moved up 4.93% to $16.81 in the pre-market session. DF's PEG ratio is 1.04. Nabors Industries Ltd NBR gained 3.96% to $13.90 in the pre-market session. NBR's trailing-twelve-month revenue is $6.58 billion.